Stockscreener 앱 받기
28.13
1.82%
-0.52
시간 외 거래:
28.50
0.37
+1.32%
전일 마감가:
$28.65
열려 있는:
$28.84
하루 거래량:
2.81M
Relative Volume:
1.24
시가총액:
$3.55B
수익:
$715.22M
순이익/손실:
$-250.10M
주가수익비율:
-13.86
EPS:
-2.03
순현금흐름:
$-205.58M
1주 성능:
+2.03%
1개월 성능:
+16.24%
6개월 성능:
+8.19%
1년 성능:
-28.40%
1일 변동 폭
$27.84
$28.97
1주일 범위
$27.14
$28.97
52주 변동 폭
$16.10
$41.94
아펠리스 Stock (APLS) Company Profile
명칭
Apellis Pharmaceuticals Inc
전화
617-977-5700
주소
100 FIFTH AVENUE, WALTHAM, KY
APLS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APLS
Apellis Pharmaceuticals Inc
|
28.13 | 3.62B | 715.22M | -250.10M | -205.58M | -2.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
아펠리스 Stock (APLS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-09 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-05-09 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-17 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-11-21 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-10-25 | 개시 | RBC Capital Mkts | Sector Perform |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-10-16 | 개시 | William Blair | Outperform |
| 2024-05-31 | 개시 | Piper Sandler | Neutral |
| 2024-02-05 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-12-14 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-11-09 | 개시 | Goldman | Buy |
| 2023-11-02 | 개시 | Mizuho | Neutral |
| 2023-10-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-09-15 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-08-29 | 재확인 | Citigroup | Buy |
| 2023-08-03 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-08-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-01-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-11-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-19 | 개시 | H.C. Wainwright | Buy |
| 2022-06-17 | 재개 | Stifel | Buy |
| 2022-04-14 | 다운그레이드 | ROTH Capital | Neutral → Sell |
| 2021-12-08 | 개시 | Wells Fargo | Overweight |
| 2021-11-29 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2021-09-10 | 재확인 | BMO Capital Markets | Outperform |
| 2021-09-10 | 재확인 | Credit Suisse | Neutral |
| 2021-09-10 | 재확인 | Needham | Buy |
| 2021-09-10 | 재확인 | Oppenheimer | Outperform |
| 2021-09-10 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-08-19 | 개시 | Jefferies | Buy |
| 2021-08-19 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2021-05-21 | 개시 | UBS | Buy |
| 2021-04-16 | 개시 | Goldman | Buy |
| 2020-11-19 | 개시 | Needham | Buy |
| 2020-09-01 | 개시 | Stifel | Buy |
| 2020-07-20 | 개시 | ROTH Capital | Buy |
| 2020-06-17 | 개시 | BTIG Research | Neutral |
| 2020-04-01 | 개시 | Raymond James | Strong Buy |
| 2020-03-31 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-11 | 업그레이드 | Wedbush | Underperform → Neutral |
| 2020-01-07 | 개시 | SVB Leerink | Mkt Perform |
| 2019-12-19 | 개시 | BofA/Merrill | Buy |
| 2019-11-22 | 개시 | Wedbush | Underperform |
| 2019-11-05 | 개시 | Credit Suisse | Neutral |
| 2019-08-01 | 재확인 | Cantor Fitzgerald | Overweight |
| 2019-07-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-03-29 | 개시 | Robert W. Baird | Outperform |
| 2019-01-23 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-07-30 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-05-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-04-12 | 다운그레이드 | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-02-08 | 개시 | B. Riley FBR, Inc. | Buy |
모두보기
아펠리스 주식(APLS)의 최신 뉴스
Order flow analysis tools used on Apellis Pharmaceuticals Inc.July 2025 Macro Moves & Real-Time Volume Triggers - Newser
What is Apellis Pharmaceuticals Inc.’s valuation compared to sectorMarket Performance Summary & Expert Approved Momentum Trade Ideas - خودرو بانک
Will Apellis Pharmaceuticals Inc. benefit from rising consumer demandJuly 2025 PreEarnings & Short-Term High Return Strategies - خودرو بانک
Analyzing net buyer seller activity in Apellis Pharmaceuticals Inc.2025 Market Overview & Verified High Yield Trade Plans - Newser
What makes Apellis Pharmaceuticals Inc. stock attractive todayPortfolio Risk Report & Free Community Consensus Stock Picks - خودرو بانک
Should I hold or sell Apellis Pharmaceuticals Inc. now2025 Market Sentiment & Community Verified Trade Alerts - خودرو بانک
Using data filters to optimize entry into Apellis Pharmaceuticals Inc.Weekly Trade Analysis & Consistent Growth Stock Picks - Newser
Automated trading signals detected on Apellis Pharmaceuticals Inc.Earnings Recap Summary & AI Driven Stock Movement Reports - Newser
Has Apellis Pharmaceuticals Inc. formed a bullish divergenceEarnings Performance Report & Real-Time Chart Breakout Alerts - Newser
How Apellis Pharmaceuticals Inc. stock performs during market volatility2025 Technical Patterns & Consistent Income Trade Recommendations - Newser
Using fundamentals and technicals on Apellis Pharmaceuticals Inc.Quarterly Profit Report & Real-Time Volume Analysis - Newser
Analyzing drawdowns of Apellis Pharmaceuticals Inc. with statistical toolsJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - Newser
Transcript : Apellis Pharmaceuticals, Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 08 - MarketScreener
Can Apellis Pharmaceuticals Inc. deliver alphaJuly 2025 Short Interest & Free Real-Time Market Sentiment Alerts - خودرو بانک
Apellis Pharmaceuticals shares fall 2.01% premarket after presenting at Wells Fargo 20th. - AInvest
Apellis Pharmaceuticals Inc. stock retracement – recovery analysisChart Signals & Reliable Price Action Trade Plans - Newser
Backtesting results for Apellis Pharmaceuticals Inc. trading strategiesTrade Risk Assessment & Daily Volume Surge Trade Alerts - Newser
Will Apellis Pharmaceuticals Inc. stock benefit from interest rate changesRate Cut & AI Optimized Trading Strategy Guides - Newser
What earnings revisions data tells us about Apellis Pharmaceuticals Inc.July 2025 Action & Weekly Return Optimization Alerts - Newser
Can machine learning forecast Apellis Pharmaceuticals Inc. recoveryMarket Performance Report & Long-Term Capital Growth Strategies - Newser
Apellis Pharma VP Chopas sells $15k in shares - Investing.com
Can trapped investors hope for a rebound in Apellis Pharmaceuticals Inc.Buy Signal & Comprehensive Market Scan Insights - Newser
What’s the MACD signal for Apellis Pharmaceuticals Inc.Trade Risk Assessment & Weekly High Return Forecasts - خودرو بانک
Transcript : Apellis Pharmaceuticals, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-03-2025 08 - MarketScreener
What data driven models say about Apellis Pharmaceuticals Inc.’s futureEarnings Miss & Short-Term High Return Strategies - Newser
How is Apellis Pharmaceuticals Inc. managing supply chain issuesWeekly Trend Recap & Growth Focused Stock Reports - خودرو بانک
Should value investors consider Apellis Pharmaceuticals Inc.July 2025 News Drivers & Community Consensus Stock Picks - خودرو بانک
What’s the beta of Apellis Pharmaceuticals Inc. stockQuarterly Earnings Summary & Fast Entry Momentum Alerts - خودرو بانک
Key metrics from Apellis Pharmaceuticals Inc.’s quarterly dataJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - Newser
What’s the profit margin of Apellis Pharmaceuticals Inc.Dollar Strength & Real-Time Stock Movement Alerts - خودرو بانک
Is Apellis Set for a Rebound? - timothysykes.com
Is Apellis Pharmaceuticals Inc. stock a value trap2025 Earnings Impact & High Return Trade Guides - خودرو بانک
Will Apellis Pharmaceuticals Inc. stock recover after recent dropRecession Risk & Safe Capital Investment Plans - Newser
Is Apellis Pharmaceuticals Inc. meeting your algorithmic filter criteriaOptions Play & Consistent Profit Focused Trading Strategies - Newser
Published on: 2025-09-01 23:36:26 - Newser
What the charts say about Apellis Pharmaceuticals Inc. today2025 Performance Recap & Entry Point Strategy Guides - Newser
What to do if you’re stuck in Apellis Pharmaceuticals Inc.Market Activity Summary & Expert Verified Stock Movement Alerts - Newser
How cyclical is Apellis Pharmaceuticals Inc.’s revenue streamMarket Sentiment Report & Entry and Exit Point Strategies - خودرو بانک
Published on: 2025-09-01 19:43:22 - Newser
Real time social sentiment graph for Apellis Pharmaceuticals Inc.Quarterly Trade Review & Reliable Entry Point Alerts - Newser
Has Apellis Pharmaceuticals Inc. found a price floor2025 Market Outlook & Low Drawdown Momentum Trade Ideas - Newser
Apellis Pharmaceuticals Inc. Recovery Gathers Momentum on Chart Signals getLinesFromResByArray error: size == 0 - 강소기업뉴스
Is Apellis Pharmaceuticals Inc. reversing from oversold territoryWeekly Profit Recap & Daily Oversold Stock Bounce Ideas - Newser
How to track smart money flows in Apellis Pharmaceuticals Inc.July 2025 Trends & Precise Swing Trade Entry Alerts - Newser
Have Insiders Sold Apellis Pharmaceuticals Shares Recently? - simplywall.st
Apellis Pharmaceuticals Inc. stock momentum explained2025 Top Gainers & Smart Allocation Stock Tips - Newser
아펠리스 (APLS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):